J. Proeve, Ph.D., an expert with 35+ years of experience as Global Data Management Head at Bayer started this week as Chief Scientific Officer at Cyntegrity. 
He takes the responsibility of building up a proper Risk-based Monitoring (RBM) strategy for each clinical study and develop further Cyntegrity’s core product RBM – EarlyBird.
“We welcome Dr. Proeve and believe, as a team, we can bring the RBM concept to new frontiers, make it absolutely essential for patient safety, clinical trials transparency and improved data quality.” (A. Andrianov)
Leave A Comment
You must be logged in to post a comment.